
InsCer starts commercial production of a radiopharmaceutical used to diagnose Alzheimer’s disease
On Tuesday (26), the Brain Institute (InsCer) of PUCRS started commercial production of the radiopharmaceutical, Florbetaben (18F), which is used in the differential diagnosis of Alzheimer’s disease. InsCer is a pioneer in producing this product in Brazil. As well as manufacturing this...
26 de Abril de 2022